⌘K

Login Start Free

Home/Filings/4/0000899243-16-021564

4//SEC Filing

Seres Therapeutics, Inc. 4

Accession 0000899243-16-021564

$MCRBCIK 0001609809operating

View on SEC.gov Company Profile

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 9:38 PM ET

Size

4.7 KB

Accession

0000899243-16-021564

Insider Transaction Report

Form 4

Period: 2016-06-01

Seres Therapeutics, Inc.MCRB

See Remarks

Transactions

Sale
Common Stock
2016-06-01$29.43/sh−16,000$470,880→ 144,673 total

Footnotes (1)

[F1]The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2016.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Seres Therapeutics, Inc.

CIK 0001609809

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001609809

Filing Metadata

Form type: 4
Filed: Jun 1, 8:00 PM ET
Accepted: Jun 2, 9:38 PM ET
Size: 4.7 KB

View on SEC.gov